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The assessment of medical outcomes is important in the effort to contain costs, 
streamline patient management, and codify medical practices. As such, it is 
necessary to develop predictive models that will make accurate predictions of 
these outcomes. The neural network methodology has often been shown to 
perform as well, if not better, than the logistic regression methodology in terms of 
sample predictive performance. However, the logistic regression method is 
capable of providing an explanation regarding the relationship(s) between 
variables. This explanation is often crucial to understanding the clinical 
underpinnings of the disease process. Given the respective strengths of the 
methodologies in question, the combined use of a statistical (i.e., logistic 
regression) and machine learning (i.e., neural network) technology in the 
classification of medical outcomes is warranted under appropriate conditions. The 
study discusses these conditions and describes an approach for combining the 
strengths of the models.  
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INTRODUCTION 
The study of patient outcomes has become increasingly important in the effort to contain medical 
costs, streamline patient management, and codify practices. Such study has aided the recent 
efforts to implement disease management programs (i.e., the application of outcomes principles 
to the practices of healthcare providers). By being able to predict the likelihood of a patient event 
prior to its occurrence, a case manager may learn to forestall or delay the event.  
To study the feasibility of such an approach, a patient population has been selected (Medicare 
beneficiaries suffering from congestive heart failure [CHF] with identifiable outcomes [mortality 
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within a specified period after discharge]). We develop neural network models and a model based 
on the logistic regression method, compare these approaches, and recommend a possible 
combined approach. 
Neural networks have been used extensively in many industries including health care. They 
have, for instance, been the subject of extensive study and application in biomedicine and have 
been used to create diagnostic aides, analyze medical images, and to develop drugs. However, 
there has been limited use in the management of health care and so we investigate the possibility 
of their use in this area here. 
For instance, issues such as the quality and management of patient care, the allocation of 
scarce resources, and the funding and reimbursement of institutional and provider services have 
dominated our discussions of the health care delivery system for the last 20 years. Since the 
formulation, analysis, and hoped for conclusion of these issues is dependent on the accurate 
portrayal of patient and administrative data, it is imperative that such data be efficiently and 
accurately mined for their contribution to these issues. This study tests the presumption that the 
use of neural networks to predict patient outcomes is valid and that its accuracy is comparable to 
that of conventional statistical approaches. 
BACKGROUND 
Neural Nets 
A neural network (NN) is a software- and/or hardware-based system of interconnected nodes (or 
neurons) that “learns” by modifying the connection strengths (or weights) between its elements in 
order to match the input-output behavior of the network to the process or system being 
modeled[1]. NNs are frequently composed of many computational elements operating in parallel. 
These computational nodes or neurons are connected via weights that are typically adapted to 
improve the performance of the network. 
NN models are developed via training; the process of weight adaptation as prescribed by a set 
of well-defined rules[2]. The most common forms of learning include: (1) supervised learning 
(e.g., backpropagation) and (2) unsupervised learning (e.g., Kohonen self-organizing NN). 
Supervised learning requires the pairing of an input vector with a target vector (a training pair). 
With supervised learning, an NN is trained so that the application of a set of vector inputs will 
produce the set of vector outputs. Often, the NN “learns” through the minimization of error 
between the actual and estimated outputs. This occurs over many training iterations (epochs) 
since: (1) the initial weights are unlikely to provide the desired outputs and (2) many training 
pairs may be presented to a network. Incremental adjustments are made to the weights of a 
network until they gradually converge on an optimal set of values. This paper compares the 
performance of two supervised learning techniques. The training algorithms include: (1) 
multilayer perceptron (MLP) or backpropagation and (2) radial basis function (RBF).   
The backpropagation method[3] is a very popular training algorithm in which an input vector 
is disseminated through a network in a forward fashion and the corresponding target output 
(actual) compared with the network derived output (estimated). Typically, the difference between 
the actual and the estimated outputs are calculated and the weights adjusted so as to minimize the 
sum-squared error. The modified errors are propagated back to the preceding nodes and layers 
(excluding the input layer) whereby the weights attached are adjusted to further minimize the 
sum-squared error. This process is repeated for the entire training set or matrix. As such, the input 
vectors are applied sequentially, errors calculated, and weights adjusted for each vector until the 
error for the entire training set is either at an acceptably low level (determined by the investigator) 
or a predetermined training duration had been reached. 
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The RBF network[4] is a supervised, feed-forward NN with a single hidden layer. Unlike 
multilayer networks, which transform a weighted summation of inputs, radial basis networks 
determine the outputs (each of which represents a basis function) of the hidden layer by 
measuring the distance between the network input and the center (or centroid) of each RBF.  
Logistic Regression 
Logistic regression can be characterized as a modeling approach, which can be used to describe 
the relationship of several independent variables to a dichotomous dependent variable[5]. As such 
it lends itself to the classification of a dichotomous outcome such as the presence and occurrence 
or absence and nonoccurrence of a disease or event.  
The logistic function is a squashing function that transforms an input with a value between + 
infinity, into an output in the range [0,1]. The function f(z) indicates the risk for the presence or 
absence of a disease or event 
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where z = b + w1p1 +w2p2+ … wkpk is an index of combined risk factors. Since in the domain for 
z of + infinity, f(z) ranges from 0 to 1, it can clearly be used to describe the probability or risk of 
an event or disease occurring. 
The S-shaped curve of the logistic function provides a mechanism to consider the impact of a 
threshold on the likelihood of an outcome or risk for disease. The shape of the curve indicates that 
the effect of z will be negligible in the limit to – infinity. However as z increases, its impact will 
increase until a threshold is reached and so the risk or likelihood of the event (disease) rises 
rapidly over an intermediate range of values and then remains extremely high as z tends to + 
infinity. 
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= P(D = 1|x1, x2, …xk), whereby D = 1 represents the occurrence of the disease. 
Congestive Heart Failure 
CHF is described as a disease process associated with profound symptoms and a poor long-term 
prognosis[6,7]. Its symptoms are characterized by abnormalities of the left and right ventricular 
function and are generally accompanied by changes in neurohormonal regulation, effort 
intolerance, fluid retention, and decreased survival. CHF is neither rare nor benign. It is often 
terminal, occurring after all reserve capacity and compensatory mechanisms of the myocardium 
and peripheral circulation have been exhausted. For many patients, the predominant symptom of 
CHF is a reduction of functional capacity due to poor exercise tolerance resulting from limited 
cardiac reserve[8,9]. 
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DATA SOURCES 
The abstract patient data used for model development are provided by Louisiana Health Care 
Review (LHCR). Note: all unique patient and provider identifiers have been deleted from the data 
set and replaced with integers randomly assigned to each individual. The data form a subset of the 
Medicare (Part A) patient discharge database (fiscal 1990 to 1994) and includes all Louisiana 
hospital beneficiaries who are residents of the state. 
Because the data set contains longitudinal patient data, it can be used to track a patient’s 
passage through the prospective payment system. The data set contains all admission records 
(CHF or otherwise) of Louisiana patients with at least one principal diagnostic code (the 
admitting diagnosis) of CHF (n = 53,289). In addition, a smaller clinical data set is used to 
supplement the analysis. The clinical data set contains information from the LHCR’s statewide 
baseline review. There are 1,068 records within the clinical data set. A listing of the variables 
included within the data sets is provided in Appendix A.   
The study population includes all Medicare (Part A) beneficiaries who were admitted to a 
Louisiana hospital during the fiscal years 1991 through 1994 (October 1, 1990 through September 
30, 1994). The study sample includes all Louisiana residents (within the study population) with at 
least one recorded episode (a principal diagnostic code) of CHF. 
There are 35,271 persons included in the study sample. Of these, 20,986 (59.5%) are female; 
14,275 (40.5%) male. Within the study sample, 24,984 (70.8%) are classified as “white”, 8,861 
(25.1%) “black”, and; 1,145 (3.3%) “other” or “unknown”. The study sample ranges in age from 
64 to 109 years of age. 
The definition of CHF (as provided LHCR) will include the principal diagnostic codes shown 
in Table 1. It should be noted the definition differs from the New York Heart Association’s 
(NYHA) classification of CHF[10].  
TABLE 1 
CHF Codes 
Diagnosis 
Codes 
Description 
402.01  Hypertensive Heart Disease, Malignant with CHF 
402.11  Hypertensive Heart Disease, Benign with CHF 
402.91  Hypertensive Heart Disease, Unspecified with CHF 
404.01  Hypertensive Heart & Renal Disease, Malignant with CHF 
404.03  Hypertensive Heart & Renal Disease, Malignant with CHF & Renal Failure 
404.13  Hypertensive Heart & Renal Disease, Benign with CHF & Renal Failure 
404.91  Hypertensive Heart & Renal Disease, Unspecified with CHF 
404.93  Hypertensive Heart & Renal Disease, Unspecified with CHF & Renal Failure 
425.4  Other Cardiomyopathies — Includes Congestive 
428.0  Heart Failure, CHF 
428.1  Heart Failure, Left Heart Failure — Includes Left Ventricular Failure 
428.9  Heart Failure, Unspecified 
429.3  Ill Defined Descriptions & Complications of Heart Disease, Cardiomegaly — 
Includes Dilation, Hypertrophy, Ventricular Dilation 
518.4  Acute Edema of Lung, Unspecified, Acute Pulmonary Edema NOS; Pulmonary 
Edema, Postoperative 
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MODEL DEVELOPMENT  
The study design is retrospective, correlational, and nonexperimental. We first surveyed the 
literature to identify a preliminary set of independent variables.   
Training, Testing, and Validation of Logistic Regression Model 
In this phase, outcome or dependent variables were created that identify the mortality of a 
beneficiary within 90 and 365 days of discharge. The outcome variables are dichotomous and 
identify survival or death within a specified period after discharge. The variables were coded 0 
(event did not occur) and 1 (event did occur), respectively, i.e., patient did not die within a 
specified time period vs. patient did die within a specified time period after discharge. Where 
appropriate, both the claims and clinical data sets were linked to create a combined data set (n = 
1,024).   
In addition, dummy variables were developed for race (White, Black), principal diagnosis 
(CHF, Unspecified with CHF), principal procedure (No Procedure, Operations on the 
Cardiovascular System), left ventricular hypertrophy from EKG and past MI from EKG. Dummy 
variables were also created for EKG-related categories in order to account for instances where an 
EKG was not administered. Interaction terms for the sociodemographic variables age, sex, race, 
and Metropolitan Statistical Area (MSA) were also developed as possible candidates for the 
development of the logistic regression model(s). 
Two subsets of the database were created for the training and testing of the logistic regression 
models. The training set was used explicitly for model development, while the testing set was 
used to compare the predictive performances of the various (90- and 365-day) logistic regression 
and NN models. 
In order to develop models, variables of significance to be considered as candidates for model 
development have to be determined. So tests for association between the outcome and dependent 
variables were generated using chi-square (categorical variables) and the Student t test 
(continuous variables). A significance level of 0.2 was chosen for each test and results are shown 
in Tables 2 and 3, respectively.   
The development of the “final” model was a three-step process involving the creation of two 
intermediary and a conclusive logistic regression model. A forward (conditional) stepwise 
approach was applied to the development of the models. The entry of variables was based on the 
significance of the score statistic (<0.05). The removal (or exit) of variables was based on the 
significance (<0.1) of the likelihood ratio statistic (using conditional parameter estimates). The 
method of contrast was the “Indicator” method. The method testifies to the absence or presence of 
membership within a category. The reference group is by default the last category.  
The first intermediary model was generated by “entering” all first-order terms in Block 1 of 
the logistic regression model. All second-order terms were included in Block 2 of the model. A 
forward (conditional) stepwise approach was applied to Block 2 of the model (entry: 0.05; 
removal: 0.1). 
The second intermediary model was generated by “entering” in Block 1 all first- and second-
order terms relevant to Block 2 of the previous or first intermediary model. The remaining first-
order terms were included in Block 2 of the model. A forward (conditional) stepwise approach 
was applied to Block 2 of the model (entry: 0.05; removal: 0.1). 
The “final” or conclusive model was generated by entering: (1) all first- and second-order 
terms from Block 1 of the second intermediary model and (2) all second-order terms relevant to 
Block 2 of the second intermediary model (entry: 0.05; removal: 0.1). 
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Table 2A 
Mortality within 90/365 Days of Discharge — Pearson Chi-Square 90 Days  
Bivariate Test of Independence (<0.2) 
Variable  Value  DF  p 
Cardiomyopathy on X-ray  2.58606  1  0.10781 
Pleural effusion on X-ray  10.94007  1  0.00094 
Discharge with ACE inhibitor  29.65021  1  0.00000 
History of CABG  2.32166  1  0.12758 
History of ischemic cardiomyopathy  2.69313  1  0.10078 
History of hypertension  2.41583  1  0.12011 
History of MI  2.50583  1  0.11343 
History of renal disease  2.47928  1  0.11535 
History of valvular heart disease  6.76347  1  0.00930 
Indicator for rales on physical examination  2.60122  1  0.10678 
Indicator for angina  3.53947  1  0.05992 
Absence of left ventricular hypertrophy (EKG)  2.44909  1  0.11759 
Presence of left ventricular hypertrophy (EKG)  5.52327  1  0.01877 
Absence of MI (EKG)  6.45249  1  0.01108 
Presence of MI (EKG)  4.83719  1  0.02785 
Principal diagnosis (CHF)  3.30803  1  0.06894 
Principal procedure (Ops on Cardvasc Syst)  2.53491  1  0.11135 
Table 2B 
Mortality within 90/365 Days of Discharge — Pearson Chi-Square 365 Days  
Bivariate Test of Independence (<0.2) 
Variable  Value  DF  p 
Absence of left ventricular hypertrophy (EKG)  3.46354  1  0.06274 
Presence of left ventricular hypertrophy (EKG)  3.64885  1  0.05611 
Cardiomyopathy on X-ray  5.09732  1  0.02396 
Pleural effusion on X-ray  9.59183  1  0.00195 
Discharge with ACE inhibitor  9.43953  1  0.00212 
History of ischemic cardiomyopathy  3.47372  1  0.06235 
History of cardiomyopathy  2.85043  1  0.09135 
History of hypertension  4.97780  1  0.02567 
History of MI  4.49899  1  0.03391 
History of renal disease  2.86993  1  0.09025 
History of valvular heart disease  7.68126  1  0.00558 
Symptoms of angina  5.74095  1  0.01657 
Symptoms of fatigue  4.25461  1  0.03914 
Probabilities for the occurrence (or nonoccurrence) of the event were developed for the 
beneficiaries within the testing set and receiver operating characteristic (ROC) curves were used 
to identify the cut-off point. In addition, cross-tabulations were used to compare the predicted 
outputs of the logistic regression models and the actual occurrences of the event. 
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Table 3A 
Mortality within 90 Days of Discharge Student t Test for Independent Samples Shaded 
Area: Variables of Significance 
Variable  p 
(Levene's 
Test for 
Variances) 
Variance DF  2-Tail 
Significance 
95% CI for Diff 
Age  0.164  Equal  498  0.001  (–4.896, –1.339) 
Blood, urea, and nitrogen 
(BUN) 
0.000  Equal  490  0.000  (–12.522, –6.456) 
Creatinine  0.006  Equal  492  0.023  (–0.207, –0.016) 
Potassium  0.002  Equal  493  0.033  (–0.295, –0.012) 
Pulse 0.402  Unequal  116  0.243 (–8.122,  2.080) 
Diastolic BP  0.252  Unequal  131  0.000  (7.358, 14.882) 
Systolic BP  0.431  Unequal  135  0.000  (12.934, 26.087) 
Left ventricular dimensions 
(diastole) 
0.813 Unequal  24  0.966  (–0.601, 0.576) 
Left ventricular dimensions 
(systole) 
0.725 Unequal  21  0.368  (–0.972, 0.376) 
Left ventricular assessment 
(ventriculogram) 
0.077 Equal  6 0.281 (–17.031, 49.031) 
Left ventricular assessment 
(MUGA) 
N/A N/A  N/A  N/A  N/A 
Ejection fraction (assessment 
prior to admission) 
0.383 Unequal  19  0.788  (–9.621, 12.498) 
Ejection fraction (current 
echo) 
0.145 Equal  135  0.708 (–8.127, 11.935) 
Ejection fraction (current 
calculated) 
0.659  Unequal  21  0.146  (–2.551, 16.099) 
Fractional shortening  0.937  Unequal 10  0.910  (–8.336,  9.248) 
Length of stay  0.000  Equal  498  0.007  (–2.294, –0.370) 
Total charge  0.001  Equal  498  0.001  (–4818, –1151) 
Development of the Neural Network 
Predictors identified by the previous models were used to create the NNs. They provide the input 
layer of the NN — the output node will comprise the patient outcome (it is binary). The following 
training algorithms were applied to the training set: (1) MLP or backpropagation and (2) RBF.   
The choice of activation functions, number of hidden layers and nodes, and the final mean-
squared error at termination were recorded. Random initialization of the weights was performed 
during model development. As with the development of the logistic regression models, the 
probabilities of the occurrence (or nonoccurrence) of the event were developed for the 
beneficiaries within the testing set and ROC curves were used to identify the probability cut-off 
point. Again cross-tabulations compared predicted outputs of the neural network models and 
actual event occurrences. 
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Table 3B 
Mortality within 360 Days of Discharge Student t Test for Independent Samples Shaded 
Area: Variables of Significance 
Variable  p 
(Levene's 
Test for 
Variances) 
Variance DF  2-Tail 
Significance 
95% CI for Diff 
Age  0.051  Equal  498  0.017  (–3.276, –0.326) 
Blood, urea, and nitrogen 
(BUN) 
0.000  Equal  490  0.000  (–10.732, –6.548) 
Creatinine  0.001  Equal  490  0.001  (–0.202, –0.051) 
Potassium  0.003  Equal  493  0.001  (–0.305, –0.074) 
Pulse  0.038  Equal  498  0.169  (–6.786, 1.191) 
Diastolic BP  0.628  Unequal  326  0.000  (4.869, 11.231) 
Systolic BP  0.291  Unequal  363  0.000  (10.746, 21.569) 
Left ventricular dimensions 
(diastole) 
0.884  Unequal  70 0.999  (–0.394,  0.394) 
Left ventricular dimensions 
(systole) 
0.233  Unequal  58 0.427  (–0.735,  0.316) 
Left ventricular assessment 
(ventriculogram) 
N/A  N/A N/A  N/A  N/A 
Left ventricular assessment 
(MUGA) 
0.727  Unequal  11 0.925 (–15.550,  16.978) 
Ejection fraction (assessment 
prior to admission) 
0.360  Unequal  48 0.326  (–4.131,  12.195) 
Ejection fraction (current 
echo) 
0.608  Unequal  56 0.979  (–7.612,  7.819) 
Ejection fraction (current 
calculated) 
0.306  Unequal  60 0.353  (–3.638,  10.047) 
Fractional shortening  0.039  Equal 73  0.529  (–7.043,  3.652) 
Length of stay  0.273  Unequal  296  0.131  (–1.473, 0.191) 
COMPARING PERFORMANCES OF LOGISTIC REGRESSION AND NEURAL 
NETWORK MODELS 
The models were used to predict outcomes within the testing set. All ROC curves were reviewed 
and analyzed in order to compare the predictive performances of the various logistic regression 
and NN models. The measures of comparison include the following: overall accuracy, sensitivity, 
specificity, and Area Under Curve (Az).   
Logistic Regression Model 
We used several tests to evaluate the 90- and 365-day logisitic regression models. They include 
likelihood, Hosmer–Lemeshow test, ROC curves, and a z statistic. We first present a detailed 
discussion and results for the 90-day model and then a synopsis of the 365-day results. 
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90-Day Model 
A sample of 484 cases was used to develop the 90-day logistic regression model. The variables 
(including interaction terms) that were identified as significant (p < 0.05) to the prediction of 
death within 90 days of discharge are seen in the Table 4A. The variable age was also included in 
order to develop the interaction terms: age by absence of left ventricular hypertrophy (EKG); age 
by presence of left ventricular hypertrophy (EKG).   
Table 4A 
Significant Variables: Logisitic Regression Model — 90 Days 
Variables Significance  p 
Absence of left ventricular hypertrophy  p = <0.01 
Presence of left ventricular hypertrophy  p = <0.05 
Pleural effusion on X-ray  p = <0.01 
Blood, urea, and nitrogen (BUN)  p = <0.001 
Creatinine  p = <0.05 
Discharge with ACE inhibitor  p = <0.001 
Presence of MI (EKG)  p = <0.01 
History of valvular heart disease  p = <0.05 
Systolic BP  p = <0.01 
Age by absence of left ventricular hypertrophy (EKG)  p = <0.01 
Age by presence of left ventricular hypertrophy  p = <0.025 
The certainty of the observed results (given the parameters of the model) is identified as the 
likelihood. Since likelihood <1, it is customary to use –2 multiplied by the log of the likelihood, 
or –2 log likelihood (–2LL) as a measure of model fit. The likelihood of a perfect fit for a model 
(to its data set) is 1 (the value of –2LL is 0). The –2LL for the 90-day logistic regression model 
(constant only) is 452.50. The –2LL for the model is 338.83; as the model improves, the value of 
–2LL decreases.   
The model chi-square measures the difference between the –2LL for the model with constant 
only and the –2LL for the current model. It tests the null hypothesis that the coefficients for 
variables added at the last step are 0. Note: measure is comparable to the overall F statistic in 
linear regression. The model chi-square for the 90-day logistic regression model is 113.67 with 12 
degrees of freedom. Since the test statistic is significant (p < 0.0000), we can reject the null 
hypothesis.  
Goodness of fit measures indicate how well a model fits data. So next we used the Hosmer-
Lemeshow test, which is a variant of the goodness of fit statistic[11]. It tests the null hypothesis 
that the model provides a poor fit to the data; it should be noted that if a model fits well with its 
data, the difference between the observed and predicted values based on the fitted model will be 
small and (as a consequence) the goodness of fit statistic will be nonsignificant. The Hosmer-
Lemeshow statistic for the 90-day model is 8.928 with p > 0.3 where a small p value (p < 0.1) 
would have indicated a poor fit between the observed and expected outcomes as seen in Table 
5A. Table 6A shows the distribution of probabilities for the test.  
An ROC curve[12] was generated to assess the predictive performance of the 90-day logistic 
regression model against the testing set of 294 cases (see Fig. 1A). Cut-offs, which maximized 
the overall accuracy of the model, were identified and using a cut-off of 0.10, the accuracy of the  
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Table 5A 
Mortality within 90/365 Days of Discharge Logistic Regression Model. Calculation of 
Hosmer-Lemeshow Statistic — 90 Days 
Goodness of fit (Hosmer-Lemeshow test)
Observed counts
D i e d  9 0 123456789 1 0 T o t a l
1 013158 1 1 1 0 1 2 3 4
0 4 94 84 64 84 44 13 83 93 71 6
T o t a l 4 94 94 94 94 94 94 94 94 95 0
Expected Counts
D i e d  9 0 123456789 1 0 T o t a l
8 5
4 0 6
4 9 1
1 0.53292 1.1393 1.76513 2.68127 3.9885 5.56195 8.26746 11.99561 17.61442 31.45355 85.00011
0 48.46708 47.8607 47.23487 46.31873 45.0115 43.43805 40.73254 37.00439 31.38558 18.54645 405.99989
T o t a l 4 94 94 94 94 94 94 94 94 95 0
(O - E)^2 / E
D i e d  9 0 123456789 1 0 T o t a l
4 9 1
1 0.53292 0.0170319 0.8639046 1.0542276 0.2565206 1.0687057 0.9031522 0.3319931 1.7895402 0.2061582 7.0241541
0 0.0058597 0.0004054 0.0322834 0.0610265 0.0227305 0.1368406 0.1833123 0.1076213 1.0043374 0.3496307 1.9040477
Total 0.5387797 0.0174374 0.896188 1.1152541 0.279251 1.2055463 1.0864645 0.4396143 2.7938776 0.5557889 8.9282018
Test statistic follows a chi-square distribution with 8 df
p-value =  0.348389   indicating good fit
A small p-value (< 0.10) would indicate expected counts far from observed  ->  poor fit.
to get p-value : use CHIDIST(calc sum of (O-E)^2/E , degrees of freedom) = CHIDIST(9.49372,8)  
Table 6A 
Probability Distribution of Outcomes for 90-Day Logistic Regression  
Model — Administrative and Clinical Data Testing Set 
Probability 
of Death 
Death within 90 
Days of 
Discharge 
(Actual) 
Survived within 
90 Days of 
Discharge 
(Actual) 
Total 
0.00–0.09 11  240  251 
0.10–0.19 18  75 93 
0.20–0.29 11  42 53 
0.30–0.39 5  25  30 
0.40–0.49 8  12  20 
0.50–0.59 13  7 20 
0.60–0.69 5  4 9 
0.70–0.79 8  1 9 
0.80–0.89 4  0 4 
0.90–1.00 2  0 2 
Total 85  406  491 
model was 43% (sensitivity: 77%; specificity: 36%). Note: cut-offs may be manipulated to 
determine a sufficiently high sensitivity while maintaining an acceptably low false positive rate (1 
- specificity). The area under the ROC curve (Az) was determined. The calculation of the Az and 
its standard error is based on the independence or correlation of the sample(s) under study. The 
comparison of independent samples utilizes the Mann-Whitney U statistic to calculate the Az and 
its standard error. The comparison of correlated samples (test values derived from same sample,  
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FIGURE 1A. ROC curve mortality within 90 days of discharge logistic regression. Test data: ______ Az: 0.55. 
Table 7A 
Model Performance Comparison of Area Under the Curve:  
Administrative and Clinical Data Testing Set — 90-Day Models 
Model AZ 95%  CI SE  One-Tail  p Two-Tail  p 
Log 0.55  (0.47,  0.65)  0.0456 0.1237  0.2474 
MLP 0.55  (0.45,  0.65) 0.0517  0.1397  0.2795 
BB 0.66  (0.57,  0.75)  0.0446 0.0003  0.0007 
RBF 0.65  (0.56,  0.75) 0.0479  0.0006  0.0012 
equal sample size, cases in same order) utilizes the degree of correlation of the curves in order to 
increase the statistical power of the comparison[13]. Both approaches were used to compare the 
performances of the various models under consideration. 
The Mann-Whitney U statistic has a well-characterized distribution that approaches normality 
as sample size increases. This feature enables the use of the z statistic to determine the degree to 
which the test or predictive model is superior to the “line of no information” (Az = 0.5). It tests 
the null hypothesis that the observed Az was obtained by chance. One- and two-tailed p values 
are then generated by way of the z statistic.  
A z statistic was calculated by dividing the difference between the Az and the line of no 
information with the standard error of the Mann-Whitney U statistic in order to determine the 
degree to which the model is superior to the line of no information. It tests the null hypothesis 
that the Az was obtained by chance. One- and two-tailed p values were then generated by way of 
the z statistic. The Az for the 90-day logistic regression model was 0.55 (one-tail p: 0.1237; two-
tail p: 0.2474). Since the test statistic is nonsignificant, we cannot reject the above null hypothesis 
(see Table 7A for detail). 
365-Day Model 
Our analysis follows that for the 90-day model above. A sample of 485 cases was used to develop 
the 365-day logistic regression model and the variables identified as significant (p < 0.05) to the 
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prediction of death within 365 days of discharge are in Table 4B. Again the variable age was also 
included in order to develop the interaction terms.  
Table 4B 
Significant Variables: Logisitic Regression Model — 365 Days 
Variables Significance  p 
Absence of left ventricular hypertrophy (EKG)  p = <0.05 
Cardiomyopathy on X-ray  p = <0.025 
Pleural effusion on X-ray  p = <0.025 
Blood, urea, and nitrogen (BUN)  p = <0.001 
Symptoms of angina  p = <0.025 
History of MI  p = <0.025 
Pulse  p = <0.001 
History of valvular heart disease  p = <0.01 
Diastolic BP  p = <0.001 
Age by absence of left ventricular hypertrophy (EKG)  p = <0.05 
Age by cardiomyopathy on x-ray  p = <0.05 
Age by symptoms of angina  p = <0.025 
Here the –2LL for the 365-day logistic regression model (constant only) is 609.26 and the –
2LL for the model is 494.77. The model chi-square for 365 days is 114.50 with 14 degrees of 
freedom. Since this test statistic is significant (p < 0.0000), we can reject the null hypothesis as 
for 90 days.  
The Hosmer-Lemeshow statistic now is 7.06 with p > 0.5 (a small p value [p < 0.1]) again 
indicating a poor fit between the observed and expected outcomes in Table 5B. Goodness of fit 
results are in Table 6B. 
The ROC curve assessed the 365-day logistic regression model against the testing set of 256 
cases (see Fig. 1B). With a cut-off of 0.41, the overall accuracy of the model was 57% 
(sensitivity: 70%; specificity: 50%).   
One- and two-tailed p values were generated again and the Az for the 365-day logistic 
regression model was 0.60 (one-tail p: 0.0048; two-tail p: 0.0096). Since the test statistic is 
significant, we can reject the null hypothesis. Table 7B illustrates this in contrast to the 90-day 
case. 
Neural Network Models 
To develop the models, the variables significant (p < 0.05) to the prediction of mortality within 
90/365 days of discharge were used as input to develop the respective MLP and RBF models 
(Table 8A). A training set of 152 cases was used to train the 90-day NN models and 285 cases for 
the 365-day models. A validation set of 18 cases was used to cross-validate the performance of 
the models during training for the 90-day model and 32 for the 365-day model.  
Two layers (including the hidden and output layers) were used to develop the MLP or 
backpropagation network. The number of nodes within each layer was selected automatically. 
The number of nodes within the input layer total 18 and 4 in the hidden layer for 90 days and 21 
and 5, respectively, for 365 days. The activation function for the hidden layer is a tangent sigmoid 
and the activation function for the output layer is linear. 
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Table 5B 
Mortality within 90/365 Days of Discharge Logistic Regression Model. Calculation of 
Hosmer-Lemeshow Statistic — 365 Days 
Goodness of fit (Hosmer-Lemeshow test)
Observed counts
D i e d  3 6 5 123456789 1 0 T o t a l
1 2 6 5 8 16 13 20 21 22 41 154
0 4 64 24 34 03 23 52 82 72 61 0
T o t a l 4 84 84 84 84 84 84 84 84 85 1
Expected Counts
D i e d  3 6 5 123456789 1 0 T o t a l
3 2 9
4 8 3
1 2.57008 4.86842 6.89034 9.04235 11.21979 14.21217 17.35373 21.57054 27.0023 39.36049 154.09021
0 45.42992 43.13158 41.10966 38.95765 36.78021 33.78783 30.64627 26.42946 20.9977 11.63951 328.90979
T o t a l 4 84 84 84 84 84 84 84 84 85 1
(O - E)^2 / E
D i e d  3 6 5 123456789 1 0 T o t a l
4 8 3
1 0.1264518 0.2630162 0.518608 0.1201561 2.0366163 0.1033872 0.4035297 0.0150908 0.926699 0.0682917 4.5818467
0 0.0071537 0.0296876 0.0869233 0.0278891 0.6212691 0.0434877 0.2285024 0.0123164 1.1917022 0.230937 2.4798684
Total 0.1336055 0.2927038 0.6055312 0.1480452 2.6578854 0.1468749 0.632032 0.0274072 2.1184012 0.2992286 7.0617151
Test statistic follows a chi-square distribution with 8 df
p-value =  0.529989   indicating good fit
A small p-value (< 0.10) would indicate expected counts far from observed  ->  poor fit.
to get p-value : use CHIDIST(calc sum of (O-E)^2/E , degrees of freedom) = CHIDIST(9.49372,8)  
Table 6B 
Probability Distribution of Outcomes for 365-Day Logistic Regression Model — 
Administrative and Clinical Data Testing Set 
Probability 
of Death 
Death within 365 
Days of Discharge 
(Actual) 
Survived within 365 
Days of Discharge 
(Actual) 
Total 
0.00–0.09 4  68  72 
0.10–0.19 17  96  113 
0.20–0.29 21  57  78 
0.30–0.39 26  45  71 
0.40–0.49 24  29  53 
0.50–0.59 15  21  36 
0.60–0.69 17  7 24 
0.70–0.79 12  4 16 
0.80–0.89 15  2 17 
0.90–1.00 5  0 5 
Total 156  329  485 
90-Day Model 
A total of 86 weights were generated by the 90-day MLP model. The conjugate gradient descent 
method was used to alter nodal weights during training; the initialization of weights was random. 
The conjugate gradient method measures the gradient of the error surface after each backward 
and forward propagation of the model. It then adjusts nodal weights in order to minimize the 
mean-square error. After training of the NN model is terminated, the root mean square (RMS) 
error was recorded. The RMS error for the 90-day MLP network was 0.52. 
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FIGURE 1B. ROC curve mortality within 365 days of discharge logistic regression. Test data: _____ AZ: 0.60. 
Table 7B 
Model Performance Comparison of Area Under the Curve:  
Administrative and Clinical Data Testing Set — 365-Day Models 
Model AZ 95%  CI  SE  One-Tail  p Two-Tail  p 
Log 0.60  (0.53,  0.67)  0.0370 0.0048  0.0096 
MLP 0.69  (0.62,  0.76) 0.0348  0.0000  0.0000 
BB 0.65  (0.58,  0.72)  0.0357 0.0000  0.0001 
RBF 0.67  (0.61,  0.75) 0.0353  0.0000  0.0000 
Table 8A 
Significant Variables: Neural Network Models — 90 Days 
Variables Significance  p 
Absence of left ventricular hypertrophy  p = <0.01 
Presence of left ventricular hypertrophy  p = <0.05 
Pleural effusion on X-ray  p = <0.01 
Blood, urea, and nitrogen (BUN)  p = <0.001 
Creatinine  p = <0.05 
Discharge with ACE inhibitor  p = <0.001 
Presence of MI (EKG)  p = <0.01 
History of valvular heart disease  p = <0.05 
Systolic BP  p = <0.01 
Age by absence of left ventricular hypertrophy (EKG)  p = <0.01 
Age by presence of left ventricular hypertrophy  p = <0.025 
Two layers (including the hidden and output layers) were used to develop the 90-day RBF 
network. The number of nodes within the input layer total 18. The activation function for the 
output layer is a spline function whereby f(x) = d
2logd (where d = distance of x from a centroid). 
The positional strategy for the initial centroids was based on a sampling of data points and the 
distance measure in use was Euclidean. A total of 30 centroids (reflecting the optimal number of 
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centers within the data set) were generated by the 90 RBF model. Note: the number of centroids 
chosen can range from 5 to 50. The RMS error for the 90-day RBF network was 0.62.   
A ROC curve was again used to assess the performance of the 90-day MLP model (see Fig. 
2A). Using a cut-off of 0.82, the accuracy of the model was 72% (sensitivity: 41%; specificity: 
78%). The Az for the 90-day MLP network was 0.55 (one-tail p: 0.1397; two-tail p: 0.2795). 
Since the test statistic is nonsignificant, we cannot reject the null hypothesis (see Table 7A for 
details). For the 90-day RBF model (see Fig. 2B) with a cut-off of 0.51, the accuracy now was 
62% (sensitivity: 68%; specificity: 61%). The Az was 0.65 (one-tail p: 0.0006; two-tail p: 
0.0012), and now since the test statistic is significant, the null hypothesis is rejected (Table 7A). 
 
FIGURE 2A. ROC curve mortality within 90 days of discharge MLP. Test data: _____ Az: 0.55. 
 
FIGURE 2B. ROC curve mortality within 90 days of discharge RBF. Test data: _____ AZ: 0.65. 
365-Day Model 
The significant variables for the 365-day model are seen in Table 8B and again, age developed 
the interaction terms.   
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Table 8B 
Significant Variables: Neural Network Models — 365 Days 
Variables Significance  p 
Absence of left ventricular hypertrophy (EKG)  p = <0.05 
Cardiomyopathy on X-ray  p = <0.025 
Pleural effusion on X-ray  p = <0.025 
Blood, urea, and nitrogen (BUN)  p = <0.001 
Symptoms of angina  p = <0.025 
Symptoms of fatigue  p = <0.025 
History of MI  p = <0.025 
Pulse  p = <0.001 
History of valvular heart disease  p = <0.01 
Diastolic BP  p = <0.001 
Age by absence of left ventricular hypertrophy (EKG)  p = <0.05 
Age by cardiomyopathy on X-ray  p = <0.05 
Age by symptoms of angina  p = <0.025 
 
FIGURE 3A. ROC curve mortality within 90 days of discharge MLP. Test data: _____ AZ: 0.69. 
A total of 122 weights were used for the MLP model, again with conjugate gradient descent 
for training with random initialization of weights. The RMS error after training was 0.61. 
As for the 90-day example, two layers were used to develop the 365-day RBF network with a 
similar approach. A total of 20 centroids were generated and the RMS error here was 0.59. 
The ROC curve for the 365-day MLP model is seen in Figure 3A. Here with a cut-off of 0.58, 
the accuracy of the model was 72% (sensitivity: 57%; specificity: 80%). The Az for was 0.69 
(one-tail p: 0.0000; two-tail p: 0.0000) and the null was rejected due the significance of the test 
statistic (Table 7B). 
For the RBF, the ROC curve is in Figure 3B. Now with a cut-off of 0.53, the model’s 
accuracy was 67% (sensitivity: 58%; specificity: 72%) and the Az was 0.67 (one-tail p: 0.0000; 
two-tail p: 0.0000). Again the test statistic is significant, and we can reject the null hypothesis as 
seen in Table 7B. 
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FIGURE 3B. ROC curve mortality within 90 days of discharge multilayer RBF. Test data: _____ AZ: 0.67. 
RESULTS 
Comparison of Logistic Regression and Neural Network Models 
A comparison of the 90-day logistic regression and NN models reveals the following: (1) we 
accept (do not reject) the null hypothesis that no difference exists between the Az of the logistic 
regression and MLP network (chi-square = 0.0038; df = 1; one-tail p = 0.4753; two-tail p = 
0.9506); (2) we reject the null hypothesis that no difference exists between the Az of the logistic 
regression and RBF network (chi-square = 2.2177; df = 1; one-tail p = 0.0682; two-tail p = 
0.1364).  
Similarly for the 365-day cases we see: (1) we reject the null hypothesis that no difference 
exists between the Az of the logistic regression and MLP network (chi-square = 5.8766; df = 1; 
one-tail p = 0.0077; two-tail p = 0.0153); (2) we reject the null hypothesis that no difference 
exists between the Az of the logistic regression and RBF network (chi-square = 4.2225; df = 1; 
one-tail p = 0.0200; two-tail p = 0.0399). 
Based on the findings for the study population, we accept (do not reject) the assertion stating 
that NNs represent a valid approach to predicting patient outcomes. Given the parameters of the 
study, it has also been shown that NNs can outperform the logistic regression model in terms of 
sample prediction. 
Table 9 provides a comparison of the sensitivity, specificity, positive predictive value, and 
negative predictive value of the various models. 
Limitations 
The study has determined that: (1) NNs represent a valid approach to predicting the mortality of 
the study population within a specified period after discharge and (2) NNs are able to outperform 
the logistic regression in terms of sample prediction.   
Several limiting factors should be taken into account when considering the results of this 
study. These limitations relate to the study's methodological approach, the paucity of clinical 
predictors, the reliance on default parameters in the development of the NN models, and the 
nature of the disease process identified as CHF. 
For example, the study's approach to the development of the logistic regression model carries 
inherent limitations that may hinder its performance. It should be noted that a logistic regression 
model forces a linear relationship between a continuous predictor and the predicted log odds of its  
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Table 9A 
Model Performance Comparison of Sensitivity and Specificity Administrative and  
Clinical Data Testing Set — 90-Day Models 
Model  Cut-Off  Overall  Sens  95% CI  Spec  95% CI  PPV  NPV 
Log 0.10  0.43  0.77  (0.6216, 
0.8853) 
0.36 (0.3043, 
0.4270) 
0.18 0.90 
MLP 0.82  0.72  0.41  (0.2634, 
0.5675) 
0.78 (0.7192, 
0.8261) 
0.24 0.88 
BB 0.38  0.54  0.77  (0.6216, 
0.8853) 
0.50 (0.4363, 
0.5637) 
0.21 0.93 
RBF 0.51  0.62  0.68 (0.5242, 
0.8139) 
0.61 (0.5486, 
0.6727) 
0.24 0.92 
n = 294. 
Table 9B 
Model Performance Comparison of Sensitivity and Specificity Administrative and  
Clinical Data Testing Set — 365-Day Models 
Model  Cut-Off  Overall  Sens  95% CI  Spec  95% CI  PPV  NPV 
Log 0.41  0.57  0.70  (0.5950, 
0.7897) 
0.50 (0.4118, 
0.5702) 
0.44 0.74 
MLP 0.58  0.72  0.57  (0.4631, 
0.6722) 
0.80 (0.7276, 
0.8564) 
0.62 0.77 
BB 0.95  0.65  0.04  (0.0118, 
0.1065) 
0.99 (0.9564, 
0.9985) 
0.67 0.64 
RBF 0.53  0.67  0.58 (0.4738, 
0.6822) 
0.72 (0.6486, 
0.7910) 
0.55 0.75 
n = 256.  
outcome variable. Information is lost when a nonlinear relationship is thus forced into a linear 
relationship. Since the logistic regression models contain continuous predictors that may harbor a 
nonlinear relationship with its outcome variable, the threat of such a loss must be acknowledged. 
If a nonlinear relationship does exist between a continuous predictor and its outcome variable, it 
is advisable to capture it by converting the continuous into categorical variables. 
The paucity of clinical predictors is another limiting component of model development. Many 
of the variables available simply had too many missing values to be of use. Note: one example 
includes the numerous predictors that pertain to ejection fraction or its subjective assessment. 
The predictors eventually selected via model development include historical (pertaining to the 
presence or absence of a condition), radiographic (pertaining to the presence or absence of a 
condition or a treatment regimen), and laboratory data (pertaining to BUN, creatinine, and 
potassium values); it should be noted that these values have the advantage of simplicity and 
availability. Little information was captured with respect to ejection fraction (a variable widely 
thought to be an indicator of poor health within a population suffering from CHF) or its 
colloraries. 
The reliance on default parameters in the development of the NN models is another limiting 
factor of model development. In order to enforce a uniformity of approach to  network 
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development (and thus support the study's comparative efforts), it was decided to rely only on the 
default parameters available to the software program. As such, the optimization of each NN 
model was sacrificed for uniformity. It is anticipated that individual efforts to optimize the 
performance of each network will result in a marked improvement of their performances. This 
effort is recommended if the models are to be used within an applied setting. 
The nature of CHF is another limiting component of model development. Rightly identified 
as a syndrome, its lack of specificity is reflected in the data and may have hindered model 
development. 
CONCLUSIONS 
Neural networks represent a broad class of nonlinear regression (e.g., MLP or backpropagation 
network) and discriminant models (e.g., ADALINE); data reduction and nonlinear dynamical 
systems (e.g., Kohonen self-organizing network)[14]. They are oftentimes similar or identical to 
popular statistical techniques (e.g., generalized linear models, principal components, cluster 
analysis, polynomial regression), particularly if the emphasis were on the prediction, rather than 
the explanation of outcomes. Such similarities may account for their strengths. As such, they have 
much to offer by way of data analysis and classification. 
It has been shown that given the parameters of the study and its sample, the NN methodology 
is superior to the logistic regression methodology in terms of sample prediction performance. It 
must be noted, however, that the use of the logistic regression methodology (or statistical 
methods in general) should not be overlooked. On the contrary the logistic regression 
methodology is capable of providing an explanation (either intuitive or explicit) regarding the 
relationship(s) between: (1) the outcome and the independent variables (multivariate analyses) 
and (2) the dependent variables (bivariate analyses). Also, statistical software programs can also 
be used to produce confidence intervals, prediction intervals, diagnostics, and various graphical 
displays — features that are rarely provided by NN technologies[14].  
The study therefore recommends that the combined use of statistical and machine learning 
technologies in the classification of medical/patient outcomes is warranted when: (1) information 
regarding the relationship(s) between variables is/are unclear, i.e., the exercise of producing a 
logistic regression is helpful to the understanding of relationships (both statistical and clinical) 
between variables; and (2) improving the predictive performance of a model is critical for clinical 
or disease management purposes. It also recommends an approach that is similar to the study's 
methodology.  
The study recommends that future research efforts should include the application of NN 
technology within a patient or disease management setting. In addition, other candidates for 
further research may include: (1) the prediction of continuous outcomes from recorded healthcare 
data, (2) the prediction of discrete outcomes from transient (or real time) healthcare data, and (3) 
the prediction of continuous outcomes from transient (or real time) healthcare data. 
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APPENDIX A 
Administrative Claims Data 
The following variables are included within the claims data set (n = 157,432): patient identifier 
(arbitrary); facility identifier (arbitrary); Prospective Payment System (PPS) code; non-PPS claim 
code; record link; age; sex; race; Zip code; Louisiana resident; Metropolitan Statistical Area 
(MSA); urban/rural designation of hospital (HCFA); Diagnosis-Related Group (DRG); principal 
diagnosis group; secondary diagnosis group (1 to 9 diagnostic codes available); procedure code (1 
to 6 diagnostic codes available); DRG price (price HCFA utilizes to assess payment); total charge 
(billing by hospital); reimbursement (amount paid to HCFA); Intensive Care Unit (ICU) stay; 
Coronary Care Unit (CCU) stay; in-patient death; admission date; (elapsed); discharge date 
(elapsed); date of death (elapsed); bad bill indicator; index; admission date (actual); discharge 
date (actual); date of death (actual). 
Clinical Data 
The following variables are included within the clinical data set (n = 1,024): assessment of left 
ventricular systolic function prior to admission; method of past assessment of left ventricular 
function; ejection fraction from past assessment; past subjective assessment of left ventricular 
function (if ejection fraction missing); echocardiogram for current admission; ejection fraction 
from echocardiogram; subjective assessment of left ventricular function (if ejection fraction 
missing from echocardiogram); MUGA for current admission; left ventricular function from 
MUGA; subjective assessment of left ventricular function (if assessment missing from MUGA); 
left ventriculogram for current admission; left ventricular assessment from ventriculogram; 
subjective assessment of left ventricular function (if assessment missing from ventriculogram); 
left ventricular internal dimensions (diastole); left ventricular internal dimensions (systole); 
fractional shortening (calculated from left ventricular internal dimensions [diastole and systole]); 
ejection fraction (calculated from left ventricular internal dimensions [diastole and systole]); low 
ejection fraction indicator; admission blood pressure (systole); admission blood pressure 
(diastole); admission pulse; Blood, Urea, Nitrogen (BUN) admission value; admission creatinine 
value; admission potassium value; indicator for shortness of breath; indicator for dypsnea on 
exertion; indicator for othopnea; indicator for paroxysmal nocturnal dypsnea; indicator for 
fatigue; indicator for angina; indicator for S3 gallop from physical examination; indicator for 
displace point of maximum impulse on physical examination; indicator for rales on physical 
examination; history of CHF; history of ischemic heart disease; history of myocardial infarction; 
history of CABG; history of PTCA; history of renal disease; history of hypertension; history of 
diabetes; history of angina; history of atrial fibrillation; history of valvular heart disease; history 
of renovascular disease; history of adverse reaction to ACE inhibitors; history of cardiomyopathy; 
history of ischemic cardiomyopathy; history of nonischemic cardiomyopathy; history of 
hypertrophic cardiomyopathy; history of nonspecified cardiomyopathy; X-ray for current 
admission (yes/no); indicator for congestion on X-ray; indicator for edema on X-ray; indicator for 
pulmonary vascular congestion on X-ray; indicator for cardiomyopathy on X-ray; indicator for 
pleural effusion on X-ray; indicator that X-ray is unclear; second X-ray for current admission 
(yes/no); indicator for congestion on second X-ray; indicator for edema on second X-ray; 
indicator for pulmonary vascular congestion on second X-ray; indicator for cardiomyopathy on 
second X-ray; indicator for pleural effusion on second X-ray; EKG for current admission 
(yes/no); indicator for normal EKG; indicator for past MI from EKG; indicator for left ventricular 
hypertrophy from EKG; EKG rhythm; patient admitted with ACE inhibitor (yes/no); patient 
discharged with ACE inhibitor (yes/no).  Submit your manuscripts at
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